MA
ALXN

MUFG Americas’s Alexion Pharmaceuticals ALXN Stock Holding History

MUFG Americas’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-5
Closed -$1K – 863
2020
Q4 		$1K Buy
+5
New +$643 ﹤0.01% 770
2020
Q2 		– Sell
-30
Closed -$3K – 737
2020
Q1 		$3K Hold
30
– – ﹤0.01% 683
2019
Q4 		$3K Hold
30
– – ﹤0.01% 716
2019
Q3 		$3K Hold
30
– – ﹤0.01% 729
2019
Q2 		$4K Hold
30
– – ﹤0.01% 743
2019
Q1 		$4K Hold
30
– – ﹤0.01% 849
2018
Q4 		$3K Hold
30
– – ﹤0.01% 694
2018
Q3 		$4K Buy
+30
New +$3.76K ﹤0.01% 712
2016
Q1 		– Sell
-299
Closed -$57K – 1262
2015
Q4 		$57K Sell
299
-217
-42% -$37.9K ﹤0.01% 565
2015
Q3 		$81K Buy
516
+67
+15% +$12.2K ﹤0.01% 545
2015
Q2 		$81K Sell
449
-50
-10% -$8.63K ﹤0.01% 550
2015
Q1 		$86K Sell
499
-17
-3% -$3.08K ﹤0.01% 576
2014
Q4 		$95K Sell
516
-4
-0.8% -$741 ﹤0.01% 575
2014
Q3 		$86K Sell
520
-141
-21% -$23.2K ﹤0.01% 595
2014
Q2 		$103K Buy
661
+99
+18% +$15.6K ﹤0.01% 569
2014
Q1 		$85K Buy
562
+186
+49% +$29.6K ﹤0.01% 588
2013
Q4 		$50K Hold
376
– – ﹤0.01% 679
2013
Q3 		$44K Sell
376
-4,000
-91% -$439K ﹤0.01% 732
2013
Q2 		$404K Buy
+4,376
New +$422K 0.01% 729

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MUFG Americas's ALXN Position: Q1 2021 in Review

MUFG Americas sold out of Alexion Pharmaceuticals (ALXN) in Q1 2021, closing a stake of 5 shares — an estimated $1K sold.

MUFG Americas first reported a position in ALXN in Q2 2013 and held it in 19 quarters. The position peaked at $404K in Q2 2013. 754 funds tracked by Wall St. Rank hold ALXN as of Q1 2021.

  • MUFG Americas reported no remaining Alexion Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • MUFG Americas sold 5 Alexion Pharmaceuticals shares in Q1 2021, an estimated $1K.
  • MUFG Americas first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 19 quarters.
  • MUFG Americas's Alexion Pharmaceuticals position peaked at $404K in Q2 2013.
  • 754 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2021.

Based on MUFG Americas's 13F filing for Q1 2021, filed 30 Apr 2021.